z-logo
open-access-imgOpen Access
Tissue-Specific Distribution of Legacy and Novel Per- and Polyfluoroalkyl Substances in Juvenile Seabirds
Author(s) -
Anna R. Robuck,
James McCord,
Mark J. Strynar,
Mark G. Cantwell,
David N. Wiley,
Rainer Lohmann
Publication year - 2021
Publication title -
environmental science and technology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.497
H-Index - 58
ISSN - 2328-8930
DOI - 10.1021/acs.estlett.1c00222
Subject(s) - bay , seabird , environmental chemistry , ether , estuary , juvenile , chemistry , biology , ecology , organic chemistry , oceanography , geology , predation
Of the thousands of per- and polyfluoroalkyl substances (PFAS) in the environment, few have been investigated in detail. In this study, we analyzed 36 legacy and emerging PFAS in multiple seabird tissues collected from individuals from Massachusetts Bay, Narragansett Bay and the Cape Fear River Estuary. PFOS was the dominant compound across multiple tissues, while long-chain perfluorinated carboxylic acids (PFCAs) dominated in brain (mean = 44% of total concentrations). Emerging perfluoroalkyl ether acids (PFEAs)-Nafion byproduct-2 and PFO5DoDA - were detected in greater than 90% of tissues in birds obtained from a nesting region downstream from a major fluorochemical production site. Compound ratios, relative body burden calculations, and electrostatic surface potential calculations were used to describe partitioning behavior of PFEAs in different tissues. Novel PFEAs preferentially partition into blood compared to liver, and were documented in brain for the first time. PFO5DoDA showed a reduced preference for brain compared to PFCAs and Nafion BP2. These results suggest future monitoring efforts and toxicological studies should focus on novel PFAS and long-chain PFCAs in multiple tissues beyond liver and blood, while exploring the unique binding mechanisms driving uptake of multi-ether PFEAs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here